Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Lu Jun Shen"'
Autor:
Hong Liang Zou, Hui Tang, Chao An, Lu Jun Shen, Ji Bin Li, Wan Yee Lau, Yi Quan Jiang, Jin Hua Huang
Publikováno v:
World Journal of Oncology. 14:125-134
Autor:
Ze-Xian Liu, Wei Xiao, Jing-Jing Zhao, Qiu-Zhong Pan, De-Sheng Weng, Yi Que, Xiao-Long Zhang, Xi-Zhi Wen, Bu-Shu Xu, Dong-Chun Hong, Tian-Hui Guo, Lu-Jun Shen, Wei-Jun Fan, Huo-Ying Chen, Hai-Rong Xu, Peng-Hui Zhou, Yi-Zhuo Zhang, Xiao-Hui Niu, Xing Zhang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Background The advent of immune checkpoint therapy has been a tremendous advance in cancer treatment. However, the responses are still insufficient in patients with soft tissue sarcoma (STS). We aimed to identify rational combinations to increase the
Externí odkaz:
https://doaj.org/article/e988ecebac5347968984760e03511f4d
Autor:
Yi-Quan Jiang, Zi-Xian Wang, Ming Zhong, Lu-Jun Shen, Xue Han, Xuxiazi Zou, Xin-Yi Liu, Yi-Nan Deng, Yang Yang, Gui-Hua Chen, Wuguo Deng, Jin-Hua Huang
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Currently, a significant proportion of cancer patients do not benefit from programmed cell death-1 (PD-1)-targeted therapy. Overcoming drug resistance remains a challenge. In this study, single-cell RNA sequencing and bulk RNA sequencing data from sa
Externí odkaz:
https://doaj.org/article/69931149762342a5b49c13e2823b4304
Autor:
Tian-qi Zhang, Zhi-mei Huang, Jing-xian Shen, Gui-qun Chen, Lu-jun Shen, Fei Ai, Yang-kui Gu, Wang Yao, Yan-yang Zhang, Rong-ping Guo, Min-shan Chen, Jin-hua Huang
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 12 (2019)
Background: In patients with a large, unresectable hepatocellular carcinoma (HCC), the primary recommendation is for transarterial chemoembolization (TACE) but used alone TACE is not typically curative. Combinations of TACE followed in a delayed fash
Externí odkaz:
https://doaj.org/article/2ec40633033e4fad953623c6f28dd950
Autor:
Dong-Chun Hong, Jing Yang, Cong Sun, Yuan-Tao Liu, Lu-Jun Shen, Bu-Shu Xu, Yi Que, Xiaojun Xia, Xing Zhang
Publikováno v:
Clinical Cancer Research.
Purpose: Radiation-induced sarcomas (RISs) have poor prognosis and lack effective treatments. Its genome and tumor microenvironment are not well characterized and need further exploration. Experimental Design: Here, we perform whole exome (WES) and m
Autor:
Wang Li, Lu-Jun Shen, Tao Chen, Xu-Qi Sun, Ying Zhang, Ming Wu, Wan-Hong Shu, Chen Chen, Chang-Chuan Pan, Yun-Fei Xia, Pei-Hong Wu
Publikováno v:
Chinese Journal of Cancer, Vol 35, Iss 1, Pp 1-9 (2016)
Abstract Background Although the prognostic impact of body mass index (BMI) in patients with non-metastatic nasopharyngeal carcinoma (NPC) had been extensively studied, its effect among metastatic NPC patients remains unknown. The purpose of this stu
Externí odkaz:
https://doaj.org/article/135fb894e12a4ac991d01557397e1c0d
Publikováno v:
World Journal of Gastrointestinal Oncology
BACKGROUND Hepatitis B virus, together with hepatitis C virus, has been recognized as the leading causes of hepatocellular carcinoma (HCC). Long non-coding RNAs (lncRNAs) have been suggested in increasing studies to be the potential prognostic factor
Publikováno v:
Disease Markers, Vol 2019 (2019)
Disease Markers
Disease Markers
Transcription factor activating enhancer binding protein 4 (TFAP4) is established as a regulator of human cancer genesis and progression. Overexpression of TFAP4 indicates poor prognosis in various malignancies. The current study was performed to qua
Autor:
Linbin Lu, Lu-Jun Shen, Zhixian Wu, Yanhong Shi, Peifeng Hou, Zengfu Xue, Cheng Lin, Xiong Chen
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68660 (2013)
BACKGROUND:Although weight loss is common in nasopharyngeal carcinoma (NPC) patients receiving radiotherapy, the prognostic influence of weight loss and its impact modified by body mass index (BMI) are still unclear. METHODS:2433 NPC patients receivi
Externí odkaz:
https://doaj.org/article/a72383fcf6bf4845b8c4dd9ea16566b9